Download PDF
Thromb Haemost 2007; 98(06): 1382-1384
DOI: 10.1160/TH07-05-0342
Letters to the Editor
Schattauer GmbH

A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation

Archibald McNicol
1   Departments of Oral Biology
2   Pharmacology & Therapeutics
,
Erin Eyer
1   Departments of Oral Biology
,
Elke C. Jackson
1   Departments of Oral Biology
,
Sara J. Israels
3   Pediatrics & Child Health
4   and the Manitoba Institute of Cell Biology University of Manitoba, Winnipeg, Manitoba, Canada
› Author Affiliations Financial support: This study was supported by the Heart and Stroke Foundation of Manitoba.
Further Information

Publication History

Received 11 May 2007

Accepted after resubmission 22 September 2007

Publication Date:
30 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Noll G. Pathogenesis of atherosclerosis: a possible relation to infection. Atherosclerosis 1998; 140: S3-S9.
    CrossrefPubMedGoogle Scholar
  • 2 Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-241.
    CrossrefPubMedGoogle Scholar
  • 3 Nieto FJ. Viruses and atherosclerosis: A critical review of the epidemiologic evidence. Am Heart J 1999; 138: S453-S460.
    CrossrefPubMedGoogle Scholar
  • 4 Valtonen VV. Role of infections in atherosclerosis. Am Heart J 1999; 138: S431-S433.
    CrossrefPubMedGoogle Scholar
  • 5 Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet 1980; 1: 1387-1389.
    PubMedGoogle Scholar
  • 6 Madjid M, Naghavi M, Litovsky S. et al. Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies. Circulation 2003; 108: 2730-2736.
    CrossrefPubMedGoogle Scholar
  • 7 Campbell LA, Kuo CC. Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 2003; 18: 48-54.
    CrossrefPubMedGoogle Scholar
  • 8 Mayr M, Kiechl S, Mendall MA. et al. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 610-615.
    CrossrefPubMedGoogle Scholar
  • 9 Armitage GC. Periodontal infections and cardiovascular disease--how strong is the association?. Oral Dis 2000; 6: 335-350.
    PubMedGoogle Scholar
  • 10 Haynes WG, Stanford C. Periodontal disease and atherosclerosis: from dental to arterial plaque. Arterioscler Thromb Vasc Biol 2003; 23: 1309-1311.
    CrossrefPubMedGoogle Scholar
  • 11 Rajasuo A, Perkki K, Nyfors S. et al. Bacteremia following surgical dental extraction with an emphasis on anaerobic strains. J Dent Res 2004; 83: 170-174.
    CrossrefPubMedGoogle Scholar
  • 12 Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999; 138: S534-S536.
    CrossrefPubMedGoogle Scholar
  • 13 Herzberg MC, Nobbs A, Tao L. et al. Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J Periodontol 2005; 76: 2101-2105.
    CrossrefPubMedGoogle Scholar
  • 14 Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis . Infect Immun 1983; 39: 1457-1469.
    PubMedGoogle Scholar
  • 15 Erickson PR, Herzberg MC. Purification and partial characterization of a 65-kDa platelet aggregationassociated protein antigen from the surface of Streptococcus sanguis . J Biol Chem 1990; 265: 14080-14087.
    PubMedGoogle Scholar
  • 16 Ford I, Douglas CW, Cox D. et al. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis . Br J Haematol 1997; 97: 737-746.
    CrossrefPubMedGoogle Scholar
  • 17 Pampolina C, McNicol A. Streptococcus sanguisinduced platelet activation involves two waves of tyrosine phosphorylation mediated by FcγRIIA and αIIbβ3. Thromb Haemost 2005; 93: 932-939.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 McNicol A, Zhu R, Pesun R. et al. A role for immunoglobulin G in donor-specific Streptococcus sanguisinduced platelet aggregation. Thromb Haemost 2006; 95: 288-293.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Bennett E, Dormandy K. Pool’s cryoprecipitate and exhausted plasma in the treatment of von Willebrand’s Disease and factor XI deficiency. Lancet 1966; 2: 731-732.
    PubMedGoogle Scholar
  • 20 Ford I, Douglas CW, Preston FE. et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Haematol 1993; 84: 95-100.
    CrossrefPubMedGoogle Scholar
  • 21 Kerrigan SW, Douglas I, Wray A. et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002; 100: 509-516.
    CrossrefPubMedGoogle Scholar
  • 22 Soberay AH, Herzberg MC, Rudney JD. et al. Responses of platelets to strains of Streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann‘s, and collagen-unresponsive patients. Thromb Haemost 1987; 57: 222-225.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006; 4: 445-457.
    CrossrefPubMedGoogle Scholar